BTNS
Developing the first trillion dollar family of drugs, membrane active immunomodulators (MAIMS).
- Stage Product In Development
- Industry Biotechnology
- Location San Antonio, TX, USA
- Currency USD
- Founded February 2008
- Employees 2
- Website btnsresearch.com
Company Summary
BTNS is a small, woman owned drug development company based in San Antonio, Texas. BTNS is developing a newly discovered class of therapeutic agents, MAIMS, that change the ways that biological molecules interact at cellular membranes. MAIMS thereby control inter-cellular signaling by controlling transmembrane signal transduction. Applications include cancer, autoimmune diseases, biodefense, ionizing radiation injury and infectious disease.
Team
-
Elzbieta IzbickaCEO
Dr. Izbicka trained in biophysics and has more than thirty years of academic and industrial experience in drug and medical device development.
-
CSO
Dr. Streeper trained in analytical pharmacology and has more than twenty five years of academic and industrial experience in drug and medical device development.
Advisors
-
Steve Wurzburg, Pillsbury Winthrop and ShawCorporate CounselUnconfirmed
Previous Investors
-
NoneUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.